Hims & Hers faces profit crunch despite growth
The bear case argued for Hims & Hers: the company is losing more money on higher revenues, creating uncertainty as it seeks a new growth engine beyond compounded GLP-1 drugs.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.